Picture of Castle Biosciences logo

CSTL — Castle Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Castle Biosciences Inc reports results for the quarter ended in March - Earnings Summary

* Castle Biosciences Inc  CSTL.OQ  reported a quarterly
adjusted
loss of 9 cents​​ per share for the quarter ended in March,
higher than the same quarter last year, when the company
reported EPS of $-1.10.  The mean expectation of nine analysts
for the quarter was for a loss of 33 cents per share. Wall
Street expected results to range from -57 cents to -17 cents per
share.
    * Revenue rose 73.6% to $72.97 million from a year ago;
analysts
expected $66.20 million. 
    * Castle Biosciences Inc's reported EPS for the quarter was
a loss
of 9 cents​.
    * The company reported a quarterly loss of $2.53 million.
    * Castle Biosciences Inc shares had risen by 3.1% this
quarter and
gained 5.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 60.9%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 9 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "strong buy"

Wall Street's median 12-month price target for Castle
Biosciences Inc is $34.00 
This summary was machine generated from LSEG data May 3 at 07:56
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.33          -0.09          Beat
 Dec. 31 2023      -0.54          -0.10          Beat
 Sep. 30 2023      -0.76          -0.26          Beat
 Jun. 30 2023      -0.91          -0.70          Beat

Recent news on Castle Biosciences

See all news